Zelboraf
My Prescription
Payment
Select pharmacy
$6,273.65
$30.00 due at pharmacy
$6,273.65 - $30.00 = $6,243.65
$6,243.65 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$6,273.65
Print or send this coupon to your phone
AlbertsonsPowered byAbout Zelboraf
Drug Details
Vemurafenib, also known by the brand name Zelboraf, is a medication used to treat specific types of cancer, including melanoma, a form of skin cancer, and Erdheim-Chester disease, a rare blood cancer. These cancers must exhibit a mutation in the BRAF gene for vemurafenib to be effective. It functions as a kinase inhibitor, specifically blocking the BRAF protein, which is responsible for cell growth. When mutated, the BRAF protein can cause cancer cells to grow and spread rapidly. By inhibiting this protein, vemurafenib helps to slow down and control tumor growth. This medication is administered in tablet form. Some potential side effects include fatigue, joint pain, and rash. Always consult with a healthcare professional before starting this treatment to ensure it is safe and suitable for your condition.
Price history for Zelboraf
112 Tablets, 240MG
Average retail price for Zelboraf
Average SaveHealth price for Zelboraf
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Zelboraf dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 240MG | 112 Tablets | $6,273.65 | $56.02 |
Zelboraf FAQs
Zelboraf is used for the treatment of certain types of melanoma, specifically melanoma that is unresectable or metastatic and has a BRAF V600E mutation. It is important for patients to have their cancer tested for this mutation before starting treatment with Zelboraf.
The cost of Zelboraf can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage prescribed. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may explore patient assistance programs or insurance options to help manage the cost.
Vemurafenib is classified as a BRAF inhibitor. It is used in the treatment of certain types of cancer, specifically those with a BRAF V600E mutation.
Yes, vemurafenib is a BRAF inhibitor.
Zelboraf is used to treat melanoma, a type of skin cancer, that has spread to other parts of the body or cannot be removed by surgery. It is specifically indicated for patients with melanoma that have a BRAF V600E mutation.